Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF‐TIMI 48 Trial

BACKGROUND: Digoxin is widely used in patients with atrial fibrillation despite the lack of randomized controlled trials. Observational studies report conflicting results regarding its association with mortality, perhaps because of residual confounding by the presence of heart failure (HF). METHODS...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Am Heart Assoc
Hoofdauteurs: Eisen, Alon, Ruff, Christian T., Braunwald, Eugene, Hamershock, Rose A., Lewis, Basil S., Hassager, Christian, Chao, Tze‐Fan, Le Heuzey, Jean Yves, Mercuri, Michele, Rutman, Howard, Antman, Elliott M., Giugliano, Robert P.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2017
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5586309/
https://ncbi.nlm.nih.gov/pubmed/28666993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.006035
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items